{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:24:10Z","timestamp":1790659450217,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12890-018-0766-6","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T01:28:34Z","timestamp":1545442114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Clinical expression of cystic fibrosis in a large cohort of Italian siblings"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-4424","authenticated-orcid":false,"given":"Vito","family":"Terlizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatello","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bisogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Braggion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Carnovale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Casciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Cirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Collura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella Miriam","family":"Di Lullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausilia","family":"Elce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzina","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Madarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Quattrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Seia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Termini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zarrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"30970","DOI":"10.1016\/j.jcf.2017.11.013","volume":"17","author":"AD Jackson","year":"2017","unstructured":"Jackson AD, Goss CH. Epidemiology of CF: how registries can be used to advance our understanding of the CF population. J Cyst Fibros. 2017;17:30970. https:\/\/doi.org\/10.1016\/j.jcf.2017.11.013 .","journal-title":"J Cyst Fibros"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","volume":"27","author":"G Veit","year":"2016","unstructured":"Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, et al. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell. 2016;27:424\u201333.","journal-title":"Mol Biol Cell"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16:45\u201356.","journal-title":"Nat Rev Genet"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T","volume":"31","author":"C Koch","year":"2001","unstructured":"Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, et al. Investigators of the ERCF: comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol. 2001;31:1\u201312.","journal-title":"Pediatr Pulmonol"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1378\/chest.130.5.1441","volume":"130","author":"EF McKone","year":"2006","unstructured":"McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006;130:1441\u20137.","journal-title":"Chest"},{"key":"766_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1375\/136905200320565256","volume":"3","author":"F Mekus","year":"2000","unstructured":"Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, T\u00fcmmler B. Categories of delta F508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2000;3:277\u201393.","journal-title":"Twin Res"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jmoldx.2013.01.001","volume":"15","author":"S Giordano","year":"2013","unstructured":"Giordano S, Amato F, Elce A, Monti M, Iannone C, Pucci P, et al. Molecular and functional analysis of the large 5\u2019 promoter region of CFTR gene revealed pathogenic mutations in CF and CFTR-related disorders. J Mol Diagn. 2013;15:331\u201340.","journal-title":"J Mol Diagn"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"e60448","DOI":"10.1371\/journal.pone.0060448","volume":"8","author":"F Amato","year":"2013","unstructured":"Amato F, Seia M, Giordano S, Elce A, Zarrilli F, Castaldo G, et al. Gene mutation in MicroRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis? PlosONE. 2013;8:e60448.","journal-title":"PlosONE"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jmoldx.2017.06.002","volume":"19","author":"M Lucarelli","year":"2017","unstructured":"Lucarelli M, Porcaro L, Biffignandi A, Costantino L, Giannone V, Alberti L, et al. A new targeted CFTR mutation panel based on next generation sequencing technology. J Mol Diagn. 2017;19:788\u2013800.","journal-title":"J Mol Diagn."},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.fertnstert.2004.03.065","volume":"82","author":"T Rossi","year":"2004","unstructured":"Rossi T, Grandoni F, Mazzilli F, Quattrucci S, Antonelli M, Strom R, et al. High frequency of (TG)mTn variant tracts in the cystic fibrosis transmembrane conductance regulator gene in men with high semen viscosity. Fertil Steril. 2004;82:1316\u201322.","journal-title":"Fertil Steril"},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2119\/molmed.2014.00229","volume":"21","author":"M Lucarelli","year":"2015","unstructured":"Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Stamato A, Narzi F, et al. A genotypic-oriented view of CFTR genetics highlights specific mutational patterns underlying clinical macro-categories of cystic fibrosis. Mol Med. 2015;21:257\u201375.","journal-title":"Mol Med"},{"key":"766_CR12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/GIM.0b013e3181ead634","volume":"12","author":"M Lucarelli","year":"2010","unstructured":"Lucarelli M, Narzi L, Pierandrei S, Bruno SM, Stamato A, d\u2019Avanzo M, et al. A new complex allele of the CFTR gene partially explains the variable phenotype of the L997F mutation. Genet Med. 2010;12:548\u201355.","journal-title":"Genet Med"},{"key":"766_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/jmedgenet-2016-103985","volume":"54","author":"V Terlizzi","year":"2017","unstructured":"Terlizzi V, Castaldo G, Salvatore D, Lucarelli M, Raia V, Angioni A, et al. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles. J Med Genet. 2017;54:224\u201335.","journal-title":"J Med Genet"},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/ajmg.10461","volume":"111","author":"F Salvatore","year":"2002","unstructured":"Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet. 2002;111:88\u201395.","journal-title":"Am J Med Genet"},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2006.07.016","volume":"131","author":"SM Blackman","year":"2006","unstructured":"Blackman SM, Deering-Brose R, McWilliams R, Naughton K, Coleman B, Lai T, et al. Relative contribution of genetic and non-genetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology. 2006;131:1030\u20139.","journal-title":"Gastroenterology"},{"key":"766_CR16","first-page":"S405","volume":"39","author":"J Zielenski","year":"2004","unstructured":"Zielenski J, Markiewicz D, Yuan X, Patel M, Sun L, Aznarez I, et al. Meconium ileus in cystic fibrosis neonates is associated with polymorphic markers in the calcium-activated potassium channel (KCNN4) gene. JPGN. 2004;39:S405\u20136.","journal-title":"JPGN"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"9320","DOI":"10.1038\/s41598-018-27465-3","volume":"8","author":"AR Philp","year":"2018","unstructured":"Philp AR, Riquelme TT, Millar-B\u00fcchner P, Gonz\u00e1lez R, Sep\u00falveda FV, Pablo Cid L, et al. Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse. Sci Rep. 2018;8:9320.","journal-title":"Sci Rep"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1210\/jc.2008-2186","volume":"94","author":"SM Blackman","year":"2009","unstructured":"Blackman SM, Hsu S, Vanscoy LL, Collaco JM, Ritter SE, Naughton K, et al. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab. 2009;94:1302\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/jama.2009.1295","volume":"302","author":"JR Bartlett","year":"2009","unstructured":"Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA. 2009;302:1076\u201383.","journal-title":"JAMA"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1038\/ncomms9382","volume":"6","author":"H Corvol","year":"2015","unstructured":"Corvol H, Blackman SM, Bo\u00eblle PY, Gallins PJ, Pace RG, Stonebraker JR, et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun. 2015;6:8382.","journal-title":"Nat Commun"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jpeds.2010.05.018","volume":"157","author":"JM Collaco","year":"2010","unstructured":"Collaco JM, Blackman SM, McGready J, Naughton KM, Cutting GR. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157:802\u20137.","journal-title":"J Pediatr"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jpeds.2012.01.042","volume":"161","author":"DM Green","year":"2012","unstructured":"Green DM, Collaco JM, KE MD, Naughton KM, Blackman SM, Cutting GR. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr. 2012;161:290\u20135.","journal-title":"J Pediatr"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/MCP.0b013e3283659f45","volume":"19","author":"MN Eakin","year":"2013","unstructured":"Eakin MN, Riekert KA. The impact of medication adherence on lung health outcomes in cystic fibrosis. Curr Opin Pulm Med. 2013;19:687\u201391.","journal-title":"Curr Opin Pulm Med"},{"key":"766_CR24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCP.0b013e32834ba899","volume":"17","author":"MS Schechter","year":"2011","unstructured":"Schechter MS. Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med. 2011;17:448\u201354.","journal-title":"Curr Opin Pulm Med"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","volume":"181S","author":"PM Farrell","year":"2017","unstructured":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181S:S4\u2013S15.e1.","journal-title":"J Pediatr"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","volume":"151","author":"VA LeGrys","year":"2007","unstructured":"LeGrys VA, Yankaskas JR, Quittell LM, Marshall BC, Mogayzel PJ Jr. Cystic Fibrosis Foundation. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr. 2007;151:85\u20139.","journal-title":"J Pediatr"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jcf.2007.12.004","volume":"7","author":"R Tomaiuolo","year":"2008","unstructured":"Tomaiuolo R, Sangiuolo F, Bombieri C, Bonizzato A, Cardillo G, Raia V, et al. Epidemiology and a novel procedure for large scale analysis of CFTR rearrangements in classic and atypical CF patients: a multicentric Italian study. J Cyst Fibros. 2008;7:347\u201351.","journal-title":"J Cyst Fibros"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ab.2006.03.022","volume":"353","author":"M Lucarelli","year":"2006","unstructured":"Lucarelli M, Narzi L, Piergentili R, Ferraguti G, Grandoni F, Quattrucci S, et al. A 96-well formatted method for exon and exon\/intron boundary full sequencing of the CFTR gene. Anal Biochem. 2006;353:226\u201335.","journal-title":"Anal Biochem"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1515\/CCLM.2011.604","volume":"49","author":"G Ferraguti","year":"2011","unstructured":"Ferraguti G, Pierandrei S, Bruno SM, Ceci F, Strom R, Lucarelli M. A template for mutational data analysis of the CFTR gene. Clin Chem Lab Med. 2011;49:1447\u201351.","journal-title":"Clin Chem Lab Med"},{"key":"766_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ejhg.2008.136","volume":"17","author":"E Dequeker","year":"2009","unstructured":"Dequeker E, Stuhrmann M, Morris MA, Casals T, Castellani C, Claustres M, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders: updated European recommendations. Eur J Hum Genet. 2009;17:51\u201365.","journal-title":"Eur J Hum Genet"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1373\/clinchem.2008.119545","volume":"55","author":"A Elce","year":"2009","unstructured":"Elce A, Boccia A, Cardillo G, Giordano S, Tomaiuolo R, Paolella G, et al. Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis. Clin Chem. 2009;55:1372\u20139.","journal-title":"Clin Chem"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. ERS global lung function initiative. Multi-ethnic reference values for spirometry for the 3\u201395 year age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324\u201343.","journal-title":"Eur Respir J"},{"key":"766_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1164\/rccm.200512-1919OC","volume":"174","author":"MD Schluchter","year":"2006","unstructured":"Schluchter MD, Konstan MW, Drumm ML, Yankaskas JR, Knowles MR. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med. 2006;174:780\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ppul.1950150204","volume":"15","author":"X Wang","year":"1993","unstructured":"Wang X, Dockery DW, WypiJ D, Fay ME, Ferris BG. Pulmonary function between 6 and 18 years of age. Pediatr Pulmunol. 1993;15:75\u201388.","journal-title":"Pediatr Pulmunol"},{"issue":"Suppl 1","key":"766_CR35","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S1569-1993(09)60006-0","volume":"8","author":"MW Konstan","year":"2009","unstructured":"Konstan MW, Wagener JS, Van Devanter DR. Characterizing aggressiveness and predicting future progression of CF lung disease. J Cyst Fibros. 2009;8(Suppl 1):S15\u20139.","journal-title":"J Cyst Fibros"},{"key":"766_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TW Lee","year":"2003","unstructured":"Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;2:29\u201334.","journal-title":"J Cyst Fibros"},{"key":"766_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","volume":"55","author":"VD Morinville","year":"2012","unstructured":"Morinville VD, Husain SZ, Bai H, Barth B, Alhosh R, Durie PR, et al. Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr. 2012;55:261\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"766_CR38","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","volume":"10","author":"D Debray","year":"2011","unstructured":"Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10:S29\u201336.","journal-title":"J Cyst Fibros"},{"key":"766_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","volume":"12","author":"A Kelly","year":"2013","unstructured":"Kelly A, Moran A. Update on cystic fibrosis-related diabetes. J Cyst Fibros. 2013;12:318\u201331.","journal-title":"J Cyst Fibros"},{"key":"766_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcf.2008.03.009","volume":"7","author":"C Castellani","year":"2008","unstructured":"Castellani C, Cuppens H, Macek M, Cassiman JJ, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros. 2008;7:179\u201396.","journal-title":"J Cyst Fibros"},{"key":"766_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jcf.2014.12.012","volume":"14","author":"V Terlizzi","year":"2015","unstructured":"Terlizzi V, Carnovale V, Castaldo G, Castellani C, Cirilli N, Colombo C, et al. Clinical expression of patients with the D1152H CFTR mutation. J Cyst Fibrosis. 2015;14:447\u201352.","journal-title":"J Cyst Fibrosis"},{"key":"766_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00018-016-2393-9","volume":"74","author":"C Castellani","year":"2017","unstructured":"Castellani C, Assael BM. Cystic fibrosis: a clinical view. Cell Mol Life Sci. 2017;74:129\u201340.","journal-title":"Cell Mol Life Sci"},{"key":"766_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/MEG.0b013e3282f36d16","volume":"20","author":"J Walkowiak","year":"2008","unstructured":"Walkowiak J, Lisowska A, Blaszczynski M. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype. Eur J Gastroenterol Hepatol. 2008;20:157\u201360.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"766_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jcf.2014.01.007","volume":"13","author":"V Terlizzi","year":"2014","unstructured":"Terlizzi V, Tosco A, Tomaiuolo R, Sepe A, Amato N, Casale A, et al. Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis. J Cyst Fibros. 2014;13:579\u201384.","journal-title":"J Cyst Fibros"},{"key":"766_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jmoldx.2014.11.007","volume":"17","author":"AC Tomaiuolo","year":"2015","unstructured":"Tomaiuolo AC, Sofia VM, Surace C, Majo F, Genovese S, Petrocchi S, et al. Relationship between CFTR and CTRC variants and the clinical phenotype in late-onset cystic fibrosis disease with chronic pancreatitis. J Mol Diagn. 2015;17:171\u20138.","journal-title":"J Mol Diagn"},{"key":"766_CR46","first-page":"22","volume":"26","author":"VM Sofia","year":"2016","unstructured":"Sofia VM, Da Sacco L, Surace C, Tomaiuolo AC, Genovese S, Grotta S, et al. Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis. Mol Med. 2016;26:22.","journal-title":"Mol Med"},{"key":"766_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2156-6-29","volume":"6","author":"O Norkina","year":"2005","unstructured":"Norkina O, De Lisle RC. Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10. BMC Genet. 2005;6:29.","journal-title":"BMC Genet"},{"key":"766_CR48","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00439-009-0724-8","volume":"126","author":"R Dorfman","year":"2009","unstructured":"Dorfman R, Li W, Sun L, Wang Y, Sandford A, Par\u00e9 PD, et al. Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results. Hum Genet. 2009;126:763\u201378.","journal-title":"Hum Genet"},{"key":"766_CR49","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1164\/rccm.200608-1164OC","volume":"175","author":"LL Vanscoy","year":"2007","unstructured":"Vanscoy LL, Balckman SM, Collaco JM, et al. Heriability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med. 2007;175:1036\u201343.","journal-title":"Am J Respir Crit Care Med"},{"key":"766_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1183\/09031936.00166412","volume":"43","author":"E Kerem","year":"2014","unstructured":"Kerem E, Viviani L, Zolin A, MacNeill S, Hatziagorou E, Ellemunter H, et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry. Eur Respir J. 2014;43:125\u201313.","journal-title":"Eur Respir J"},{"key":"766_CR51","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1378\/chest.12-2589","volume":"144","author":"LS Mott","year":"2013","unstructured":"Mott LS, Graniel KG, Park J, de Klerk NH, Sly PD, Murray CP, et al. Assessment of early bronchiectasis in young children with cystic fibrosis is dependent on lung volume. Chest. 2013;144:1193\u20138.","journal-title":"Chest"},{"key":"766_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","volume":"180","author":"PD Sly","year":"2009","unstructured":"Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180:146\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"766_CR53","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.2337\/db13-0510","volume":"62","author":"SM Blackman","year":"2013","unstructured":"Blackman SM, Commander CW, Watson C, et al. Genetic modifiers of cystic fibrosis-related diabetes. Diabetes. 2013;62:3627\u201335.","journal-title":"Diabetes"},{"key":"766_CR54","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ppul.20111","volume":"38","author":"E Picard","year":"2004","unstructured":"Picard E, Aviram M, Yahav Y, Rivlin J, Blau H, Bentur L, et al. Familial concordance of phenotype and microbial variation among siblings with CF. Ped Pulmunol. 2004;38:292\u20137.","journal-title":"Ped Pulmunol"},{"key":"766_CR55","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1651-2227.2007.00250.x","volume":"96","author":"L Minicucci","year":"2007","unstructured":"Minicucci L, Lorini R, Giannattasio A, Colombo C, Iapichino L, Reali MF, et al. Liver disease as risk factor for cystic fibrosis-related diabetes development. Acta Pediatr. 2007;96:736\u20139.","journal-title":"Acta Pediatr"},{"key":"766_CR56","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1515\/jpem-2017-0005","volume":"30","author":"N Terliesner","year":"2017","unstructured":"Terliesner N, Vogel M, Steighardt A, Gausche R, Henn C, Hentschel J, et al. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function. J Pediatr Endocrinol Metab. 2017;30:815\u201321.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"766_CR57","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jcf.2015.12.011","volume":"15","author":"WR Hunt","year":"2016","unstructured":"Hunt WR, Helfman BR, McCarty NA, Hansen JM. Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function. J Cyst Fibros. 2016;15:681\u20138.","journal-title":"J Cyst Fibros"},{"key":"766_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4193\/Rhin14.229","volume":"53","author":"A Baldan","year":"2015","unstructured":"Baldan A, Lo Presti AR, Belpinati F, Castellani C, Bettin MD, Xumerle L, et al. IFRD1 gene polymorphisms are associated with nasal polyposis in cystic fibrosis patients. Rhinology. 2015;53:359\u201364.","journal-title":"Rhinology"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0766-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-018-0766-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0766-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T23:47:45Z","timestamp":1662680865000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-018-0766-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s12890-018-0766-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"21 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We obtained from all patients (or from their legal guardian) the written consent to participate. In according to National Guidelines, observational studies do not require the formal approval by the Ethics Committee. In any case, we asked to the local ethics committee (University of Naples Federico II) that replied confirming what above and sent us the reference of the guidelines: Ministry of Health, Italian Medicines Agency, Guidelines for the Classification and Conduct of Observational Drugs Studies (2008).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"196"}}